Daxor company info

What does Daxor do?
Daxor (NASDAQ:DXR) specializes in medical instrumentation and biotechnology, focusing on innovative blood volume analysis. This unique approach provides critical information that benefits patient care in heart failure, critical care, and surgery, alongside supporting medical research. Daxor aims to revolutionize how doctors diagnose and treat heart and lung diseases by offering precise, personalized patient insights. The company's flagship product, the BVA-100 blood volume analyzer, stands at the forefront of their technology, enabling accurate measurement of blood volume and composition. Daxor's objective is to improve outcomes and reduce healthcare costs through the adoption of their blood volume analysis technology in clinical practices worldwide.
Daxor  company media
Company Snapshot

Is Daxor a public or private company?

key
Ownership
Public

How many people does Daxor employ?

people
Employees
35

What sector is Daxor in?

pie chart
Sector
Health Care

Where is the head office for Daxor ?

location pin
Head Office
New York, United States

What year was Daxor founded?

founded flag
Year Founded
1971
What does Daxor specialise in?
/Blood Volume Analyzer /Diagnostic Equipment /Medical Research /Investment Portfolio /Healthcare Solutions /Hematology Technology

What are the products and/or services of Daxor ?

Overview of Daxor offerings
BVA-100 Blood Volume Analyzer, a diagnostic device providing precise blood volume status for improved patient care.
Blood volume analysis services, aiding in diagnosis and treatment of heart failure and critical care.
R&D for advancements in blood volume measurement technology, enhancing diagnostic precision and patient outcomes.
Educational programs for healthcare professionals, focusing on the importance of blood volume measurement in clinical decisions.
Partnerships with healthcare institutions for research and development of novel diagnostic approaches.
Development of next-gen technologies for non-invasive blood volume measurement, aiming at broader clinical applications.

Who is in the executive team of Daxor ?

Daxor leadership team
  • Mr. Michael Richard Feldschuh
    Mr. Michael Richard Feldschuh
    Chairman, President & CEO
  • Mr. Jonathan Adam Feldschuh
    Mr. Jonathan Adam Feldschuh
    Chief Scientific Officer & Director
  • Mr. Robert J. Michel CPA, CPA, M.B.A.
    Mr. Robert J. Michel CPA, CPA, M.B.A.
    CFO, Chief Compliance Officer & Corporate Secretary
  • Ms. Linda  Cooper
    Ms. Linda Cooper
    Vice President of Development & Operations
  • Ms. Kathryn A. Kornafel
    Ms. Kathryn A. Kornafel
    Senior VP of Marketing & Commercial Development
  • Mr. Guido  Manzo
    Mr. Guido Manzo
    Vice President of Sales
  • Ms. Jean  Oertel
    Ms. Jean Oertel
    Senior Vice President Commercialization & Customer Experience